DYSKINESIA
AIIMS researchers pioneer breakthrough diagnostic tool for rare genetic disordersResearchers at AIIMS-Delhi have pioneered a novel transmission electron microscopy technique for diagnosing Primary Ciliary Dyskinesia and ...
Zydus Lifesciences gets USFDA nod for generic medicationZydus Lifesciences has received approval from the USFDA to market Amantadine extended-release capsules (68.5 mg) and tentative approval for...
Jefferies upgrades Zydus Life to 'Buy' on strong US pipeline potential, stock up 4%Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a 'Buy' rating, citing the strength of the company’s US pipeline as a ma...
Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...
Lupin gets USFDA nod to market generic medicationLupin has gained approval from the USFDA to market generic Valbenazine Capsules, used to treat tardive dyskinesia. This medication is equiv...
Zydus Lifesciences gets USFDA nod for 2 generic drugsThe tentative approval granted by the US Food and Drug Administration (USFDA) to the company's arm Zydus Worldwide DMCC to market Valbenazi...
Load More